<DOC>
	<DOCNO>NCT00662337</DOCNO>
	<brief_summary>The purpose study determine two formulation diphenhydramine hydrochloride bioequivalent .</brief_summary>
	<brief_title>Bioequivalence Between Two Oral Formulations Diphenhydramine Hydrochloride</brief_title>
	<detailed_description>Subjects require observe ten-hour fast one-hour fluid restriction prior dosing period . Subjects randomize one two active treatment group , receive supervised dose treatment approximately eight ounce water , require maintain fluid restriction one hour treatment . Following one-hour post-dose fluid restriction , subject could drink water , consumer food fluid four hour post-dose . Following seven-day washout period , comparison treatment administer accord procedure .</detailed_description>
	<mesh_term>Diphenhydramine</mesh_term>
	<mesh_term>Promethazine</mesh_term>
	<criteria>healthy male and/or female subject age 18 55 year , inclusive approximately 18 30 kg/m2 BMI total body weight least 55 kg ( 121 lb ) able understand sign write Informed Consent Form willing follow protocol requirement comply protocol restriction pregnant lactate woman woman childbearing potential use acceptable form contraception 3 month prior first dose completion followup procedure history allergy , sensitivity , and/or idiosyncratic reaction Benadryl , diphenhydramine hydrochloride , diphenhydramine citrate evidence clinical , dietary psychiatric deviation normal could increase risk subject research staff interfere interpretation study result use licit illicit drug participate trial within specified number day prior first dose trial treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>Bioequivalence , diphenhydramine hydrochloride</keyword>
</DOC>